Efficacy of PD‐1/PD‐L1 inhibitors in patients with advanced non‐small cell lung cancer: A meta‐analysis of randomized clinical trials

BACKGROUND: This meta‐analysis systematically evaluated the efficacy of PD‐1 and PD‐L1 inhibitors for the treatment of advanced non‐small cell lung cancer (NSCLC) and investigated the efficacy of first‐line therapy and PD‐1 versus PD‐L1 inhibitors. METHODS: PubMed, The Cochrane Library, and Embase w...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Tzu‐Rong, Wu, Ta‐Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501025/
https://www.ncbi.nlm.nih.gov/pubmed/30969033
http://dx.doi.org/10.1111/1759-7714.13060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501025/
https://www.ncbi.nlm.nih.gov/pubmed/30969033
http://dx.doi.org/10.1111/1759-7714.13060

Ejemplares similares